Cannabis Watch: Cannabis sector mixed ahead of FDA hearing on weed and its ingredients

563

Cannabis stocks were mixed Thursday, a day ahead of a key hearing by the U.S. Food and Drug Administration, seeking information and data on the substance and its ingredients with the aim of creating a regulatory framework for CBD.
The FDA will hear from all of the parties looking for clarity on the rules for CBD, which is widely believed to have wellness benefits, especially in dealing with inflammation, pain and anxiety.

Ga naar Bron